Lucy Day, Chief Financial Officer at AN2 Therapeutics, Inc. (ANTX), sold 8,807 shares at $1.00 ($9K) on 2026-01-05, disclosed to the SEC on 2026-01-07.
Open-market sale of $9k ANTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 3,295 | $3K | 37.2% |
| 2 | $1.01 | 5,512 | $6K | 62.8% |
| Total | $1.01 avg | 8,807 | $9K | 100% |